Impetigo is a common bacterial infection
caused by different kinds of bacteria, including streptococcus and
staphylococcus. It is a contagious disease and begins with appearance of red
sores on any part of the body, which eventually changes to blisters on the
body.
Request
to Get Sample Pages at:
Impetigo is
more common in warm and humid weather, is known to easily transmit in crowded
settings like schools and day care. Impetigo can be treated by topical
antibiotics, oral antibiotics and some home remedies. It is mostly found in
children, especially boys, but may also affect adults if they have a weak
immune system. Foamix Pharmaceuticals is in the process of developing FMX102
for the treatment of impetigo. Destiny Pharma plc is also involved in the
pipeline for impetigo therapeutics.
The report
provides a comprehensive understanding of the pipeline activities covering all
drug candidates under various stages of development, with the detailed analysis
of pipeline and clinical trials.
Make
Enquiry Before Buying the Report:
Pipeline
analysis of drugs by phases includes product description and development
activities including information about clinical results, designations,
collaborations, licensing, grants, technology, and others.
